SLC18A3 and Alzheimer disease: In patients with early-onset AD (age at onset <65 years) loss of cholinergic terminals were observed in the neocortex and hippocampus, whereas in patients with late-onset AD significant VAChT reductions were limited to the temporal cortex and hippocampus.